Understanding how malaria parasites develop in humans and mosquitoes

Plasmodium falciparum gametocytogenesis in vitro and in vivo

NIH-funded research Henry M. Jackson Fdn for the Adv Mil/med · NIH-10754549

This study is looking at how certain factors affect the amount of malaria parasites in their sexual stage, called gametocytes, in people who are infected, so we can find out who might be more likely to spread malaria and help create better treatments to stop it.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHenry M. Jackson Fdn for the Adv Mil/med NIH-funded
Lab location1 site (Bethesda, United States)
Project IDNIH-10754549 on NIH RePORTER

What this research studies

This research investigates the production of sexual stage malaria parasites, known as gametocytes, which are essential for malaria transmission from humans to mosquitoes. The study aims to identify factors that influence the levels of these gametocytes in the blood of infected individuals, as higher levels increase the likelihood of spreading malaria. By developing a new assay to quantify these gametocytes, researchers hope to better understand the variations in gametocyte production among patients and identify those who may be at higher risk of transmitting the disease. This could lead to targeted treatments that prevent the spread of malaria.

Who could benefit from this research

Good fit: Ideal candidates for this research are children and young individuals aged 0-21 years who are infected with malaria, particularly in regions where malaria is endemic.

Not a fit: Patients who are not infected with malaria or those outside the targeted age range may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for malaria prevention and control, ultimately reducing transmission rates.

How similar studies have performed: Previous research has shown success in understanding malaria transmission dynamics, but this specific approach to quantifying gametocyte levels is relatively novel.

Where this research is happening

Bethesda, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.